EUVIMEDEUVIMED entdecken
Open Access

Retraction: MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1

Oncology Research Editorial Office

Oncology Research · 2026 · 34 (5) · 1-10

DOI: 10.32604/or.2026.081621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Oncology Research Editorial Office. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This retracts the article DOI: 10.3727/096504018X15451308507747.].

Zitieren

APA

Oncology Research Editorial Office (2026). Retraction: MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1. Oncology Research, 34(5), 1-10. https://doi.org/10.32604/or.2026.081621

Vancouver

Oncology Research Editorial Office. Retraction: MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1. Oncology Research. 2026;34(5):1-10. doi:10.32604/or.2026.081621

BibTeX
@article{OncologyResearchEditorialOffice2026,
  author = {Oncology Research Editorial Office, Oncology Research Editorial Office},
  title = {Retraction: MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {5},
  pages = {1--10},
  doi = {10.32604/or.2026.081621}
}
Kostenlos starten →